Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply.
Saved in:
| Title: | Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply. |
|---|---|
| Authors: | Yiu TH; School of Public Health, University of Sydney, Sydney, New South Wales, Australia., Ko Y; School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.; Gastrointestinal and Liver Services Research Unit, Concord Repatriation General Hospital, Sydney, New South Wales, Australia., Pudipeddi A; Gastrointestinal and Liver Services Research Unit, Concord Repatriation General Hospital, Sydney, New South Wales, Australia., Natale P; School of Public Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Leong RW; Gastrointestinal and Liver Services Research Unit, Concord Repatriation General Hospital, Sydney, New South Wales, Australia. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (1), pp. 103-104. Date of Electronic Publication: 2024 May 23. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.18057 |
